Login
Toggle sidebar

Lint: international-myeloma-working-group-response-criteria

international-myeloma-working-group-response-criteria
Optional Plurals
error

"≥50% decrease in the sum of products of two longest perpendicular diameters (SPD) of soft tissue plasmacytoma(s) if present at baseline"

Line 43:102 · Do not use plurals in parentheses such as in 'plasmacytoma(s)'.

"≥50% decrease in the sum of products of two longest perpendicular diameters (SPD) of soft tissue plasmacytoma(s) if present at baseline"

Line 50:102 · Do not use plurals in parentheses such as in 'plasmacytoma(s)'.
Acronyms
warning

"SUVmax ≥2.5 within osteolytic area >1 cm"

Line 13:5 · 'SUV' has no definition. Spell it out if it's unfamiliar to the audience.

"SUVmax ≥1.5 within osteolytic area ≤1 cm"

Line 14:5 · 'SUV' has no definition. Spell it out if it's unfamiliar to the audience.

"imaging plus minimal residual disease (MRD)-negative refers to flow or sequencing MRD-negative in addition to disappearance of all areas of increased FDG uptake found at prior PET to an SUVmax below that of surrounding normal tissue or below that of mediastinal blood pool (Deauville 1 or 2) 2"

Line 95:214 · 'SUV' has no definition. Spell it out if it's unfamiliar to the audience.
Strong
warning

"progressive disease is defined by any of the following:"

Line 21:1 · Generally, don't use bold in text: '<strong>progressive disease</strong>'

"stable disease is a category of exclusion, i.e., the patient does not meet criteria for progressive disease, minimal response, partial response, very good partial response, or complete response"

Line 40:1 · Generally, don't use bold in text: '<strong>stable disease </strong>'

"minimal response requires all of the following:"

Line 42:1 · Generally, don't use bold in text: '<strong>minimal response</strong>'

"partial response requires all of the following:"

Line 49:1 · Generally, don't use bold in text: '<strong>partial response </strong>'

"​≥50% decrease in serum M-protein"

Line 52:1 · Generally, don't use bold in text: '<strong>​</strong>'

"​≥50% decrease in the difference between involved and uninvolved serum free light chain (FLC) levels if serum and urine M-protein unmeasurable"

Line 55:1 · Generally, don't use bold in text: '<strong>​</strong>'

"very good partial response requires any of the following:"

Line 60:1 · Generally, don't use bold in text: '<strong>very good partial response </strong>'

"​serum and urine M-protein detected by immunofixation but not electrophoresis"

Line 62:1 · Generally, don't use bold in text: '<strong>​</strong>'

"​≥90% decrease in the difference between involved and uninvolved serum free light chain (FLC) levels if serum and urine M-protein unmeasurable"

Line 69:1 · Generally, don't use bold in text: '<strong>​</strong>'

"complete response requires all of the following:"

Line 73:1 · Generally, don't use bold in text: '<strong>complete response </strong>'

"​disappearance of any soft tissue plasmacytomas"

Line 75:1 · Generally, don't use bold in text: '<strong>​</strong>'

"stringent complete response requires complete response as above plus the following:"

Line 82:1 · Generally, don't use bold in text: '<strong>stringent complete response </strong>'

"​normal free light chain (FLC) ratio (0.26-1.65)"

Line 84:1 · Generally, don't use bold in text: '<strong>​</strong>'

"flow or sequencing minimal residual disease (MRD)-negative requires absence of phenotypically abnormal clonal plasma cells from bone marrow aspirates using either a validated next-generation flow method (e.g. EuroFlow) or next-generation DNA sequencing method (e.g. LymphoSIGHT) that can detect 1 in 10 thousand nucleated cells or better"

Line 93:1 · Generally, don't use bold in text: '<strong>flow or sequencing minimal residual disease (MRD)-negative</strong>'

"imaging plus minimal residual disease (MRD)-negative refers to flow or sequencing MRD-negative in addition to disappearance of all areas of increased FDG uptake found at prior PET to an SUVmax below that of surrounding normal tissue or below that of mediastinal blood pool (Deauville 1 or 2) 2"

Line 95:1 · Generally, don't use bold in text: '<strong>imaging plus minimal residual disease (MRD)-negative </strong>'

"sustained minimal residual disease (MRD)-negative refers to imaging plus MRD-negative confirmed at least one year apart"

Line 98:1 · Generally, don't use bold in text: '<strong>sustained minimal residual disease (MRD)-negative </strong>'

"clinical relapse requires any of the following manifestations of myeloma (CRAB features):"

Line 104:1 · Generally, don't use bold in text: '<strong>clinical relapse</strong>'

"​definite (≥50% and ​≥1 cm) increase in the size (sum of products of two longest perpendicular diameters (SPD)) of measurable existing soft tissue plasmacytomas or bone lesions"

Line 107:1 · Generally, don't use bold in text: '<strong>​</strong>'

"​definite (≥50% and ​≥1 cm) increase in the size (sum of products of two longest perpendicular diameters (SPD)) of measurable existing soft tissue plasmacytomas or bone lesions"

Line 107:38 · Generally, don't use bold in text: '<strong>​</strong>'

"relapse from complete response requires reappearance/development of any of the following:"

Line 115:1 · Generally, don't use bold in text: '<strong>relapse from complete response </strong>'

"​serum or urine M-protein by immunofixation or electrophoresis"

Line 117:1 · Generally, don't use bold in text: '<strong>​</strong>'

"relapse from minimal residual disease (MRD)-negative occurs with loss of MRD-negative status (clonal plasma cells on sequencing or flow of bone marrow, or positive lesions on FDG PET) or any of the above signs of relapse from complete response"

Line 123:1 · Generally, don't use bold in text: '<strong>relapse from minimal residual disease (MRD)-negative </strong>'
Headings Valid
warning

Expected headings

  • H1 Usage
  • H1 Classification
  • H1 History and etymology
  • H1 Related pathology
  • H1 See also

"Baseline disease"

Line 3:1 · "Baseline disease" is not a recognised heading for this article type.

"Standard response criteria"

Line 18:1 · "Standard response criteria" is not a recognised heading for this article type.

"Minimal residual disease criteria"

Line 89:1 · "Minimal residual disease criteria" is not a recognised heading for this article type.

"Relapse criteria"

Line 100:1 · "Relapse criteria" is not a recognised heading for this article type.
Commas
suggestion

"stable disease is a category of exclusion, i.e., the patient does not meet criteria for progressive disease, minimal response, partial response, very good partial response, or complete response"

Line 40:59 · More than 5 commas in a single sentence might make it more difficult to read.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0